These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30262945)

  • 1. The sustainable development goals as a framework to combat health-sector corruption.
    Mackey TK; Vian T; Kohler J
    Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 3. Opening the Policy Window to Mobilize Action Against Corruption in the Health Sector Comment on "We Need to Talk About Corruption in Health Systems".
    Mackey TK
    Int J Health Policy Manag; 2019 Nov; 8(11):668-671. PubMed ID: 31779293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corruption in global health: the open secret.
    García PJ
    Lancet; 2019 Dec; 394(10214):2119-2124. PubMed ID: 31785827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corruption in Anglophone West Africa health systems: a systematic review of its different variants and the factors that sustain them.
    Onwujekwe O; Agwu P; Orjiakor C; McKee M; Hutchinson E; Mbachu C; Odii A; Ogbozor P; Obi U; Ichoku H; Balabanova D
    Health Policy Plan; 2019 Sep; 34(7):529-543. PubMed ID: 31377775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia.
    Naher N; Hoque R; Hassan MS; Balabanova D; Adams AM; Ahmed SM
    BMC Public Health; 2020 Jun; 20(1):880. PubMed ID: 32513131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Kohler JC; Bowra A
    Global Health; 2020 Oct; 16(1):101. PubMed ID: 33081805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring corruption in the South African health sector.
    Rispel LC; de Jager P; Fonn S
    Health Policy Plan; 2016 Mar; 31(2):239-49. PubMed ID: 26104821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance.
    Wong A; Perehudoff K; Kohler JC
    Glob Public Health; 2024 Jan; 19(1):2350649. PubMed ID: 38752422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corruption in Health Systems: The Conversation Has Started, Now Time to Continue it Comment on "We Need to Talk About Corruption in Health Systems".
    Lu HS; Ho BX; Miranda JJ
    Int J Health Policy Manag; 2020 Mar; 9(3):128-132. PubMed ID: 32202098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-corruption, Transparency and Accountability: Case Study of Healthcare in the Arab Countries.
    Hunter M; Uwaydah Mardini R; El-Seblani A; Elsayed S
    Glob Health Action; 2020; 13(sup1):1704529. PubMed ID: 32194015
    [No Abstract]   [Full Text] [Related]  

  • 12. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 13. [Corruption and health care system].
    Marasović Šušnjara I
    Acta Med Croatica; 2014 Jun; 68(3):243-6. PubMed ID: 26016214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good governance and corruption in the health sector: lessons from the Karnataka experience.
    Huss R; Green A; Sudarshan H; Karpagam S; Ramani K; Tomson G; Gerein N
    Health Policy Plan; 2011 Nov; 26(6):471-84. PubMed ID: 21169338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of corruption in the health sector: theory, methods and interventions.
    Vian T
    Health Policy Plan; 2008 Mar; 23(2):83-94. PubMed ID: 18281310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the universal health coverage target in the Sustainable Development Goals from a human rights perspective.
    Chapman AR
    BMC Int Health Hum Rights; 2016 Dec; 16(1):33. PubMed ID: 27978827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating health equity: the key role of universal health coverage in the Sustainable Development Goals.
    Tangcharoensathien V; Mills A; Palu T
    BMC Med; 2015 Apr; 13():101. PubMed ID: 25925656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting anticorruption interventions at the front line: developmental governance in health systems.
    Hutchinson E; Naher N; Roy P; McKee M; Mayhew SH; Ahmed SM; Balabanova D
    BMJ Glob Health; 2020 Dec; 5(12):. PubMed ID: 33272939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating social determinants of health in the universal health coverage monitoring framework.
    Vega J; Frenz P
    Rev Panam Salud Publica; 2013 Dec; 34(6):468-72. PubMed ID: 24569977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recalibrating the anti-corruption, transparency, and accountability formula to advance public health.
    Wierzynska A; Steingrüber S; Oroxom R; Bauhoff S
    Glob Health Action; 2020; 13(sup1):1701327. PubMed ID: 32194013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.